Anup Malani : Publications
"The Welfare Effects of FDA Regulation of Drugs." In The Oxford Handbook of the Economics of the Biopharmaceutical Industry, edited by Patricia Danzon and Sean Nicholson, 2012 (with Tomas Philipson).
"Economics of Infectious Diseases." In The Oxford Handbook of Health Economics, edited by Sherry Glied and Peter C. Smith, 2011 (with Ramanan Laxminarayan).
"Comment on Chapter 3, by Burman, Garrett, and Khitatrakun " In Conference on Taxes and Health Insurance: Analysis and Policy, edited by Burman and Helms. Brookings, 2008.
"Expectations Mediate Objective Physiological Placebo Effects." In vol. 20 of Neuroeconomics, Advances in Health Economics and Heatlh Services Research, edited by Dan Houser and Kevin McCabe. Emerald Publishing Group, 2008 (with Dan Houser).
"Firm Behavior in the Non-Profit Sector: A Synthesis and Empirical Evaluation." In The Governanace of Not-for-Profit Firms, edited by Edward Glaeser. NBER/University of Chicago Press, 2003.
"Implicit bias in legal interpretation." Journal of Law & Courts (forthcoming 2012) (with Ward Farnsworth and Dustin Guzior).
"Raising the Stakes in Patent Cases." Georgetown Law Review (with Jonathan Masur) (forthcoming 2012).
"The Hot–Cold Decision Triangle: A Framework for Healthier Choices." 23 Marketing Letters 457 (2012) (with Haiyang Yang, Ziv Carmon, Barbara Kahn, Janet Schwartz, Kevin Volpp and Brian Wansink).
"Accounting for Heterogeneous Treatment Effects in the FDA Approval Process." 67 Food and Drug Law Journal 23 (2012) (with Oliver Bembom and Mark van der Laan).
"Surveillance of Disease Outbreaks," 46 Journal of Human Resources 1 (2011) (with Ramanan Laxminarayan).
“Incentives for Reporting Infectious Disease Outbreaks.” 46 Journal of Human Resources 176–202 (2011) (with Ramanan Laxminarayan).
"Ambiguity about Ambiguity: An Empirical Inquiry into Legal Interpretation." 2 Journal of Legal Analysis 257 (2010) (with Ward Farnsworth and David Guzior).
"Clinical and Economic Outcomes Attributable to Healthcare-Associated Sepsis and Pneumonia." Feb. 22 Archives of Internal Medicine (2010) (with Michael Eber, Ramanan Laxminarayan, and Eli N. Perencevich).
"Corporate Philanthropy and the Market for Altruism." 109(5) Columbia Law Review 571 (2009) (with M. Todd Henderson).
"Antibiotic Overuse: The Influence of Social Norms." 207(2) Journal of the American College of Surgeons 265 (2008) (with T. Buchman, J. Dushoff, M. Effron, P. Ehrlich, S. Fitzpatrick, R. Laxminarayan, B. Levin, S. Levin, M. Lipsitch, C. Nemeroff, S. Otto, V. Patel, and J. Solomkin).
"Does Non-Profit Status Signal Quality?" 37 Journal of Legal Studies 551 (2008) (with Guy David).
"Regulation with Placebo Effects." 58 Duke Law Journal 411 (2008).
"Valuing Laws as Local Amenities." 121(5) Harvard Law Review 1273 (2008).
"The Case for For-Profit Charities." 93 Virginia Law Review 2017 (2007) (with Eric Posner).
"Introduction: Current Research in Medical Malpractice Liability." 36 Journal of Legal Studies S1 (2007).
"Habeas Settlements." 92 Virginia Law Review 1 (2006).
"Identifying Placebo Effects with Data from Clinical Trials." 114 Journal of Political Economy 236 (2006).
"Ethical Issues in Research in Complementary and Alternative Medicine." 291 Journal of the American Medical Association 2192 (2004) (letter to the editor; with Harvey Cantor).
"The Political Economy of Property Exemption Laws." 47 Journal of Law and Economics 19 (2004) (with Richard Hynes and Eric A. Posner).
"Measurement Errors: A Principal Investigator-Agent Approach." 91 Journal of Econometrics 273 (1999) (with Tomas Philipson).
"The Scope of Criminal Forfeiture under RICO: The Appropriate Definition of 'Proceeds'." 66 University of Chicago Law Review 1289 (1999).
"Determinants of Direct Foreign Investment and Its Connection to Trade." 5 UNCTAD Review 29 (1994) (with Gary Hufbauer and Darius Lakdawalla).
"Push for More Trials May Hurt Patients." Washington Examiner, July 21, 2010 (with Tomas Philipson).
"Beyond Swine Flu: Superbugs." Chicago Tribune, June 7, 2009, p. 29.
"Pay-for-delay or pay-for-innovation?" Forbes Online, July 15, 2010.
"The Right Combination of Carrots and Sticks." Resources, Fall 2009 (with Ramanan Laxminarayan).
"Capitalism 2.0." Forbes.com, March 10, 2008.
"Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance." Resources for the Future, 2007 (with Ramanan Laxminarayan, assisted by David Howard and David Smith).
"The Political Economy of Property Exemption Laws." John M. Olin Law & Economics Working Paper, no. 136. University of Chicago Law School, 2001 (with Richard Hynes and Eric A. Posner).
Working Papers (under review)
Maciej Boni, Allison Galvani, Abraham Wickelgren, and Anup Malani. Controlling Avian Influenza in Chickens (June 2012) (revise and resubmit at Proceedings of the National Academy of Sciences), product of 2007 Coase Lecture at the University of Chicago Law School.
Anup Malani and Tomas Philipson. Can Medical Progress be Sustained? Implications of the link between development and output markets (Mar 2012).
Scott Baker and Anup Malani. Does Accuracy Improve the Information Value of Trials? NBER Working Paper (Feb 2012).
Daniel Bennett, Chun-fang Chiang, Anup Malani. Learning During a Crisis: the SARS Epidemic in Taiwan, NBER Working Paper (Oct 2011).
Anup Malani and Julian Reif. "Endogeneity or Anticipation Effects? Evidence from the Effect of Tort Reform on Physician Supply”, NBER Working Paper (Oct 2011).
Ramanan Laxminarayan, Julian Reif, and Anup Malani. Can countries be incentivized to report disease outbreaks? (Feb 2011).
Amitabh Chandra, Michael Frakes, and Anup Malani. Civil rights laws and racial disparities in health care (Dec. 2010).
Emir Kamenica and Anup Malani. Do advertisements affect the physiological efficacy of branded drugs? (Mar 2009) (revise and resubmit at the Proceedings of the National Academy of Sciences).
Scott Baker and Anup Malani. “The Problem of Rational Courts.” Unpublished manuscript (June 2012).
Laszlo Jakab, Christian Leuz, and Anup Malani, The Nature and Development of Commercial Conflicts of Interest Disclosed in Medical Journal Articles (Mar 2012).
Eric Helland, Darius Lakdawalla, Anup Malani, and Seth Seabury. Unintended consequences of products liability: evidence from the pharmaceutical market (Mar 2012).
Eric Helland, Darius Lakdawalla, Anup Malani, and Seth Seabury. Tort Liability and the Market for Prescription Drugs (April 2010).
Anup Malani. Can individuals change their beliefs without altering their information set? (Jan 2010).
Ilya Beylin, Anup Malani, and David Abrams. Finding Love in the Wreckage: Estimating Spousal Altruism with Data from Fatal Car Accidents (Jan 2009).
Anup Malani. Rational Crises (Mar 2009).
Anup Malani and Ramanan Laxminarayan. Is there a fitness cost to antibiotic resistance: evidence from community-level data on E. Coli and S. Aureus (Jan 2008).
Anup Malani. Can the placebo effect be ethically studied? (June 2007).
Barton Hamilton and Anup Malani. Employing compliance to estimate heterogeneous treatment response in medical trials (May 2007).
Anup Malani and Charles Mullin. Assessing the Merits of Reallocation under Joint and Several Liability, With an Application to Asbestos Litigation (Aug 2004).
Feifang Hu and Anup Malani. The Option Value of New Therapeutics (Oct 2004).
Anup Malani and Albert Choi. Are Non-profit Firms For-profits in Disguise? Evidence from the Nursing Home Industry (Sept 2004).
Anup Malani. The Internal Validity of Clinical Trials in the Presence of Placebo Effects (Aug 2003).
Anup Malani. Does the Felony-Murder Rule Deter Crime? Evidence from FBI Crime Data (Jan 2002).
"Placebo Effects, Self-Selection, and the External Validity of Clinical Trials." PhD dissertation, University of Chicago, 2003.